Author:
Adeyanju Anne A.,Molehin Olorunfemi R.,Fakayode Aderonke Elizabeth,Ohunayo Adeniyi S.
Publisher
Springer Nature Singapore
Reference25 articles.
1. Alcoser SY, Hollingshead MG (2011) Genetically engineered mouse models in preclinical anti-cancer drug development. In: Kapetanovi I (ed) Drug discovery and development–present and future. InTech, Rijeka, pp 99–124
2. Boocock DJ, Faust GE, Patel KR et al (2007) Phase I dose escalation pharmacokinetic study in healthy volunteers of resveratrol, a potential cancer chemopreventive agent. Cancer Epidemiol Biomark Prev 16(1246)
3. Bosland MC, Prinsen MK, Kroes R (1983) Adenocarcinomas of the prostate induced by N-nitroso-N-methylurea in rats pretreated with cyproterone acetate and testosterone. Cancer Lett 18(1):69–78
4. Cooper GM (2000) The cell: a molecular approach, 2nd edn. Sinauer Associates, The Development and Causes of Cancer, Sunderland. Available from: https://www.ncbi.nlm.nih.gov/books/NBK9963/
5. da Silva Morais A, Oliveira JM, Reis RL (2018) Small animal models. Adv Exp Med Biol:423–439. https://doi.org/10.1007/978-3-319-76735-2_19